Test Price
3,000 AED✅ Home Collection Available
MeDIP Sequencing (DNA Methylation Profiling) – Advanced Epigenetic Test in UAE | 3000 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Cold‑Chain Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary Telephonic Post‑Test Clinical Guidance by Dr. Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA License 9294403), for epigenetic result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
MeDIP Sequencing offers a genome‑wide, unbiased map of DNA methylation, critical for oncological diagnostics, biological age assessment, and personalised functional medicine strategies. Our UAE‑based laboratory service delivers a 5‑week turnaround with clinically validated MeDIP‑Seq on Illumina NGS platforms, supported by DHA‑licensed clinical interpretation.
| Feature | Our MeDIP Sequencing (Premium) | Closest Alternative (Methylation Array) |
|---|---|---|
| Technology | MeDIP‑Seq with high‑sensitivity anti‑5mC antibody enrichment & Illumina NovaSeq NGS | Bisulfite conversion microarray (targeted CpG sites) |
| Coverage / Resolution | Genome‑wide, single‑base resolution, 30× depth | ~850,000 CpG sites only; limited to predefined regions |
| Turnaround Time | 5 weeks | 8–10 weeks |
| Data Analysis | Fully annotated methylation peaks with epigenome‑wide association studies (EWAS) report | Pre‑set differential methylation of limited loci |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that DNA methylation profiling offers deep insight into gene regulation that can uncover early epigenetic changes associated with cancer and aging. This test, when combined with a thorough clinical assessment, enables personalized prevention and targeted interventions. Our team is committed to guiding you through the interpretation of your results to support informed health decisions.”
— Dr. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠️ Critical Medication Warning: Do not discontinue any prescribed medication or alter your treatment plan without consulting your doctor. This test is an adjunctive epigenetic profiling tool, not a substitute for ongoing clinical management.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Recent whole blood transfusion (<4 weeks) or active severe infection may affect methylation profiles; reschedule test after recovery.
- Paediatric/Minor Consent: For individuals under 18, written informed parental/guardian consent is mandatory in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019.
- Pre‑test Notes: No special fasting or dietary restrictions. If you are taking DNA methyltransferase inhibitors (e.g., azacitidine, decitabine), please inform the laboratory for accurate interpretation.
- ER Red Flags – Seek immediate medical attention if you experience: sudden, unexplained weight loss, heavy bleeding, severe abdominal/pelvic pain, or new neurological symptoms. This test does not replace emergency evaluation.
- Limitations: MeDIP sequencing is not a stand‑alone diagnostic for active cancer. All findings must be clinically correlated by your treating specialist.
Patient FAQ & Clinical Guidance
1. What is MeDIP Sequencing and how does it benefit my health?
MeDIP Sequencing maps DNA methylation patterns across your entire genome to assess cancer risk, biological age, and epigenetic health. It provides a comprehensive snapshot of your body’s gene regulation, helping oncologists and functional medicine practitioners identify early warning signs and tailor prevention or treatment strategies far beyond conventional blood tests.
2. How is the blood sample collected and what is the turnaround time?
A certified phlebotomist collects a single whole blood sample from your home via our VIP Mobile Phlebotomy service (available 8 AM–11 PM, daily). Samples are transported under temperature-controlled cold chain to the laboratory, and results are ready within 5 working weeks.
3. Is this test covered by insurance and is it safe for elderly patients?
We verify your insurance coverage directly via WhatsApp (+971 54 548 8731). The blood draw is safe for all ages with no special preparation required. Elderly patients benefit from our gentle home collection technique, and the epigenetic data can guide healthy ageing interventions under specialist supervision.
UAE Regulatory & Data Privacy Adherence
Our laboratory strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields to ensure the confidentiality and security of your personal and health data. All clinical testing procedures and patient consent protocols comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. Our operations are conducted under DHA Facility License Number 1143, guaranteeing compliance with UAE healthcare regulations.
Clinical & Logistical Metadata
| Test Name | MeDIP Sequencing (DNA Methylation Profiling) |
| Price (AED) | 3,000 AED |
| Turnaround Time | 5 weeks |
| Sample Type / Matrix | Peripheral whole blood |
| Methodology Used | MeDIP-Seq with anti-5mC antibody enrichment and Illumina NovaSeq NGS |
| ICD-10-CM Code | Z13.89 |
| LOINC Code | 98195-0 |
| DHA Facility License & Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians